Projected epidemiological impact of lowering the adult pneumococcal vaccination age from 60 to 50 years in Germany
ABSTRACT The epidemiological impact of lowering the vaccination age of German adults from 60 to 50 y was evaluated. An age- and serotype-specific dynamic transmission model was used to evaluate the impact of vaccination with either the 23-valent pneumococcal polysaccharide vaccine (PPSV23) or the 20-valent or 21-valent...